397 related articles for article (PubMed ID: 25966631)
1. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay.
Saitsu H; Fukai R; Ben-Zeev B; Sakai Y; Mimaki M; Okamoto N; Suzuki Y; Monden Y; Saito H; Tziperman B; Torio M; Akamine S; Takahashi N; Osaka H; Yamagata T; Nakamura K; Tsurusaki Y; Nakashima M; Miyake N; Shiina M; Ogata K; Matsumoto N
Eur J Hum Genet; 2016 Jan; 24(1):129-34. PubMed ID: 25966631
[TBL] [Abstract][Full Text] [Related]
2. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results.
Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V
Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512
[TBL] [Abstract][Full Text] [Related]
3. De novo mutations of TUBB2A cause infantile-onset epilepsy and developmental delay.
Cai S; Li J; Wu Y; Jiang Y
J Hum Genet; 2020 Jul; 65(7):601-608. PubMed ID: 32203252
[TBL] [Abstract][Full Text] [Related]
4. GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype.
Arya R; Spaeth C; Gilbert DL; Leach JL; Holland KD
Epileptic Disord; 2017 Mar; 19(1):67-75. PubMed ID: 28202424
[TBL] [Abstract][Full Text] [Related]
5. The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
Datta AN; Bahi-Buisson N; Bienvenu T; Buerki SE; Gardiner F; Cross JH; Heron B; Kaminska A; Korff CM; Lepine A; Lesca G; McTague A; Mefford HC; Mignot C; Milh M; Piton A; Pressler RM; Ruf S; Sadleir LG; de Saint Martin A; Van Gassen K; Verbeek NE; Ville D; Villeneuve N; Zacher P; Scheffer IE; Lemke JR
Epilepsia; 2021 Feb; 62(2):325-334. PubMed ID: 33410528
[TBL] [Abstract][Full Text] [Related]
6. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
[TBL] [Abstract][Full Text] [Related]
7. De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.
Nakamura K; Kodera H; Akita T; Shiina M; Kato M; Hoshino H; Terashima H; Osaka H; Nakamura S; Tohyama J; Kumada T; Furukawa T; Iwata S; Shiihara T; Kubota M; Miyatake S; Koshimizu E; Nishiyama K; Nakashima M; Tsurusaki Y; Miyake N; Hayasaka K; Ogata K; Fukuda A; Matsumoto N; Saitsu H
Am J Hum Genet; 2013 Sep; 93(3):496-505. PubMed ID: 23993195
[TBL] [Abstract][Full Text] [Related]
8. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.
Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL
Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel homozygous variant confirms ITPA as a developmental and epileptic encephalopathy gene.
Kaur P; Neethukrishna K; Kumble A; Girisha KM; Shukla A
Am J Med Genet A; 2019 May; 179(5):857-861. PubMed ID: 30816001
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy.
Yang Y; Xiangwei W; Zhang X; Xiao J; Chen J; Yang X; Jia T; Yang Z; Jiang Y; Zhang Y
Dev Med Child Neurol; 2020 Oct; 62(10):1213-1220. PubMed ID: 32686847
[TBL] [Abstract][Full Text] [Related]
11. Early onset epileptic encephalopathy caused by de novo SCN8A mutations.
Ohba C; Kato M; Takahashi S; Lerman-Sagie T; Lev D; Terashima H; Kubota M; Kawawaki H; Matsufuji M; Kojima Y; Tateno A; Goldberg-Stern H; Straussberg R; Marom D; Leshinsky-Silver E; Nakashima M; Nishiyama K; Tsurusaki Y; Miyake N; Tanaka F; Matsumoto N; Saitsu H
Epilepsia; 2014 Jul; 55(7):994-1000. PubMed ID: 24888894
[TBL] [Abstract][Full Text] [Related]
12. Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.
Law CY; Chang ST; Cho SY; Yau EK; Ng GS; Fong NC; Lam CW
Clin Chim Acta; 2015 Dec; 451(Pt B):292-6. PubMed ID: 26485252
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and gene analysis of GRIN2B gene related neurological developmental disorders in children].
Tian XJ; Wang XH; Ding CH; Fang F; Dai LF; Deng J; Wang HM
Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):232-236. PubMed ID: 35240744
[No Abstract] [Full Text] [Related]
14. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A
Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224
[TBL] [Abstract][Full Text] [Related]
16. GNAO1 mutation-related severe involuntary movements treated with gabapentin.
Akasaka M; Kamei A; Tanifuji S; Asami M; Ito J; Mizuma K; Oyama K; Tokutomi T; Yamamoto K; Fukushima A; Takenouchi T; Uehara T; Suzuki H; Kosaki K
Brain Dev; 2021 Apr; 43(4):576-579. PubMed ID: 33358199
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and genetic characteristics of children with STXBP1 encephalopathy].
Cao JJ; Ji XN; Mao YY; Zhang PP; Liu WT; Zhang HZ; Ding N; Chen Q
Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):493-498. PubMed ID: 32521962
[No Abstract] [Full Text] [Related]
18. Clinical Cases and the Molecular Profiling of a Novel Childhood Encephalopathy-Causing
Larasati YA; Solis GP; Koval A; Griffiths ST; Berentsen R; Aukrust I; Lesca G; Chatron N; Ville D; Korff CM; Katanaev VL
Cells; 2023 Oct; 12(20):. PubMed ID: 37887313
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic review on GNAO1-associated movement disorder.
Feng H; Khalil S; Neubig RR; Sidiropoulos C
Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
[TBL] [Abstract][Full Text] [Related]
20. Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey.
Axeen E; Bell E; Robichaux Viehoever A; Schreiber JM; Sidiropoulos C; Goodkin HP
Pediatr Neurol; 2021 Aug; 121():28-32. PubMed ID: 34139551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
